EP Patent

EP1174118A1 — Verwendung von Inulinen und Inulinderivaten

Assigned to BASF Health and Care Products France SAS · Expires 2002-01-23 · 24y expired

What this patent protects

Die Erfindung betrifft die Verwendung von Inulinen und/oder Inulinderivaten zur Herstellung von Hautpflegemitteln.

USPTO Abstract

Die Erfindung betrifft die Verwendung von Inulinen und/oder Inulinderivaten zur Herstellung von Hautpflegemitteln.

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: EP1174118A1
Jurisdiction: EP
Classification: —
Expires: 2002-01-23
Drug substance claim: No
Drug product claim: No
Assignee: BASF Health and Care Products France SAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.